Pointe Capital Management LLC decreased its stake in Danaher Corp. (NYSE:DHR) by 5.7% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 5,005 shares of the company’s stock after selling 303 shares during the period. Pointe Capital Management LLC’s holdings in Danaher Corp. were worth $506,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in DHR. Cribstone Capital Management LLC purchased a new stake in Danaher Corp. during the second quarter valued at $132,000. Monetary Management Group Inc. boosted its stake in Danaher Corp. by 366.7% in the first quarter. Monetary Management Group Inc. now owns 1,400 shares of the company’s stock valued at $133,000 after buying an additional 1,100 shares during the period. Carnick & Kubik LLC purchased a new stake in Danaher Corp. during the first quarter valued at $171,000. Integrated Investment Consultants LLC purchased a new stake in Danaher Corp. during the second quarter valued at $179,000. Finally, Washington Trust Bank boosted its stake in Danaher Corp. by 88.4% in the second quarter. Washington Trust Bank now owns 1,950 shares of the company’s stock valued at $197,000 after buying an additional 915 shares during the period. Institutional investors own 75.74% of the company’s stock.
Shares of Danaher Corp. (NYSE:DHR) traded up 0.15% during midday trading on Wednesday, reaching $77.62. The company had a trading volume of 2,047,380 shares. The company has a market capitalization of $53.60 billion, a P/E ratio of 15.44 and a beta of 1.13. Danaher Corp. has a one year low of $61.60 and a one year high of $82.64. The company has a 50-day moving average price of $79.36 and a 200 day moving average price of $76.33.
Danaher Corp. (NYSE:DHR) last announced its quarterly earnings data on Monday, July 25th. The company reported $1.25 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.22 by $0.03. The business earned $5.80 billion during the quarter, compared to analysts’ expectations of $5.76 billion. Danaher Corp. had a return on equity of 13.40% and a net margin of 15.88%. The firm’s quarterly revenue was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.08 earnings per share. Equities analysts anticipate that Danaher Corp. will post $3.56 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, September 30th will be paid a dividend of $0.125 per share. This represents a $0.50 dividend on an annualized basis and a yield of 0.64%. The ex-dividend date is Wednesday, September 28th. Danaher Corp.’s payout ratio is 12.72%.
DHR has been the topic of several research reports. Jefferies Group restated a “buy” rating and set a $92.00 price target (down from $105.00) on shares of Danaher Corp. in a report on Friday, July 15th. JPMorgan Chase & Co. reiterated a “buy” rating and issued a $105.00 target price on shares of Danaher Corp. in a report on Thursday, June 30th. Argus reiterated a “buy” rating and issued a $90.00 target price (down from $110.00) on shares of Danaher Corp. in a report on Thursday, July 28th. Morgan Stanley reiterated a “buy” rating and issued a $86.00 target price on shares of Danaher Corp. in a report on Wednesday, August 31st. Finally, Vetr upgraded Danaher Corp. from a “hold” rating to a “buy” rating and set a $81.69 target price on the stock in a report on Monday, September 12th. Eight research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $93.98.
In other Danaher Corp. news, CFO Daniel L. Comas sold 96,446 shares of Danaher Corp. stock in a transaction on Wednesday, July 27th. The stock was sold at an average price of $80.88, for a total transaction of $7,800,552.48. Following the completion of the transaction, the chief financial officer now owns 215,716 shares in the company, valued at $17,447,110.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Thomas Patrick Joyce, Jr. sold 45,897 shares of Danaher Corp. stock in a transaction on Monday, August 1st. The shares were sold at an average price of $81.44, for a total value of $3,737,851.68. Following the transaction, the insider now owns 179,054 shares of the company’s stock, valued at approximately $14,582,157.76. The disclosure for this sale can be found here. Company insiders own 12.60% of the company’s stock.
About Danaher Corp.
Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corp. (NYSE:DHR).
Receive News & Ratings for Danaher Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corp. and related companies with MarketBeat.com's FREE daily email newsletter.